Lorenza Rimassa

71PUBLICATIONS
317CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer diagnosisCancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (71)

|Jun 10, 2026
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement.

|Jun 01, 2026
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase III FIGHT-302 Trial.

|Dec 10, 2025
Cholangiocarcinoma 2026: status quo, unmet needs and priorities.

Jesus M Banales, Pedro M Rodrigues, Silvia Affò

|Oct 08, 2025
Opportunities and Approaches to Optimising Advanced Cholangiocarcinoma Outcomes in the Era of Targeted Therapies: A Narrative Review.

Teresa Macarulla, Cindy Neuzillet, Gerald W Prager

|Sep 06, 2025
Letter Re: Reflections on the MAGIC-D Prognostic Model in Advanced Biliary Tract Cancer.

Mara Persano, Margherita Rimini, Lorenzo Fornaro

|Aug 14, 2025
Prognostic Factors and Survival Outcomes in Resected Biliary Tract Cancers: A Multicenter Retrospective Analysis.

Michele Ghidini, Fausto Petrelli, Matteo Paccagnella

Pageof 12

Frequent Collaborators

18 joint publications

Nicola Personeni

15 joint publications

Antonio D'Alessio

11 joint publications

Antonella Cammarota

9 joint publications

Tiziana Pressiani